- Email: [email protected]
Immunology congress report
Immunology Today,vol. 8, Nos 7 and 8, 7987 |
i
m,i
. . . . . .
~,~.
~
no¢es-7
,
New PublicationAvailablefor Researchers The fourth edition of Sequences of Proteins of Immunological Interest by Elvin A. Kabat, Tai Te Wu, Margaret ReidMiller, Harold M. Perry and Kay S. Gottesman is now available free of charge to persons working actively in this area. This 1987 revision of the earlier works Variable Regions of Immunoglobulin Chains and Sequences of Proteins of Immunological Interest has been further expanded to include amino acid and nucleotide sequences of precursors, variable regions, constant regions, J-chain, beta-2-microglobulins, antigens of the mouse and human major histocompatibility complex as well as of Thy 1, complement proteins, T-lymphocyte receptors for antigens, other T-cell antigens of the immunoglobulir~ superfamily, interleukins and various other proteins related to immune functions. The publication includes only those sequences which have been published or accepted for publication. As in the earlier editions, the authors used the PROPHETComputer System of the Division of Research Resources, National Institutes of Health to tabulate the data. The collection and maintenance of this database is sponsored by the following components of the National Institutes of Health: Division of Research Resources, National Cancer Institute, National Institute of Allergy and Infectious Diseases, National Institute of A,-t,htitis, Diabetes, Digestive and Kidney Diseases and National Institute of General ivledical Sciences. ~;equences of Proteins of Immunological Interest (fourth edition) is published by the Public Health Service, National Institutes of Health, U.S. Department of Health and Human Services, U.S. Government Printing Office: 1987 165-462. Copies can be obtained free of charge from Harold Perry, BBN Laboratories, Life Sciences Department, 10 Moulton Street, Cambridge, MA 02238, USA.
from $0.9 billion to $1.1 billion in 1985. Because of increased emphasis on health care products, hybridoma development showed the highest growth rates; within the sample companies performance and unemployment levels increased by 36 and 18% respectively. The report also shows that the number of people in the immunology field employed on biotechnology R&D programmes jumped by nearly 25% in the year to January 1986. According to the NSF,two thirds of this increase come from the expansion of a small number of larger companies in immunological markets. As of January 1986, immunologists now account for more than 10% of all scientists and engineers employed in biotechnology research.
In order to qualify, candidates must forward six copies of an unpublished manuscript or of recently published papers, including a curriculum vitae, to the Secretary General* before 10 December 1987. The 3000 SwissFrancs prize will be awarded during the congress.
* InternationalSocietyoi BloodTransfu~on,do CNIS-BP 100-91,943LesUlisCede.x,France.
Pew Schobrsnamed
The Pew Charitable Trusts of Philadelphia have announced the names of the 20 The NKH1/Leu19 antigenon NK cells Pew Scholars in the biomedical sciences for 1987. Recipients of the $200,000 In the paper by C.W. Reynolds and J.R. 4-year research grants are junior faculty Ortaldo (Immunol. Today 1987, 8, 172- members nominated by institutions soli174) the major population of human NK cited by the Pew Trusts. Among the 1987 cells was described as CD3, CD16+, recipients are Nilabh Shastri (UCLA BerLeu19 +. Th. Hercend of the Institut Gus- keley), Michael Snyder (Yale), Adrienne tare Roussy, ViUejuif, France, has pointed Rogalski (Univ. of Illinois), Tucker Collins out that anti-Leu19 antibodies identify (Brigham and Women's Hospital, Bosan antigen not yet included in the CD ton), Alexander Whitehead (Children's classification which he and colleagues Hospital, Boston), Alison Weiss (Virginia identified 1 and characterized2 as an NK Commonwealth Univ.) and Shing Chiu (Univ. Wisconsin, Madison). cell marker and named NKH1. 1 Griffin, J.D., Hercend, T., Beveridge, T.P. and Schlossman, S.F. (1983)J. Immunol. 130, 2947-2951 2 Hercend, T., Griffin, J.D., Bensussan, A. et al. (1985)J. C/in. Invest. 75, 932943
Erratum
We apologise to Helga Gleichmann and G.F. Bottazzo for an error in the caption to the cover photograph in our June ImmunologyCongressReport issue. The caption should have read: Islet-cell antibodies revealed by indirect immunofluorescence on blood The Medical Liaison Service of Sandoz group O human pancreas - a marker Canada Inc., Dorval, Quebec, has pubfor insulin-dependent diabetes and lished a 64-page booklet Congress Repre-diabetes. Lipofuscin granules port which contains abstracts and sumnaturally deposited in the islet stain maries of papers presented at the 1st orange. IUIS Conference on Clinical Immunology and the 6th International Congress of The authors wish to point out that their Immunology held in Toronto in July article was written on behalf of the International Diabetes Workshops Com1986. mittee which is represented by the following members: IndustrialbiotechnologyR&D Gian Franco Bottazzo, Chairman, London, UK; Helga Gleichmann, CoJeanJuillardPrize A recent report from the National Scichairman ar,d Secretary, Dusseldorf, ence Foundation (NSF) reveals that US FRG; Ake Lernmark, Chairman-Elect, The 11th Jean Juillard Prize which was industrial biotechnology research and Gentofte, Denmark; George S. Eisenestablished by the International Society development (R&D) performance topped barth, Treasurer, Boston, USA; Christthe $1 billion mark in 1985. According to of Blood Transfusion in memory of its ian Boitard, Paris, France; Roger L. the report (Science Resources Studies first Secretary General will be awarded Dawkins, Perth, Australia; Hiroo Imduring the XXth International Congress Highlights, NSF 87-304) industrial R&D ura, Kyoto, Japan; Noel K. MacLaren, in the immunological sector is of Blood Tran;fusion to b~ held in LonGainesville, USA; Aaro Miettinen, don, UK from 10 to 15 July 1988. flourishing. Helsinki, Finland; Jacques L. MoleThe prize is reserved for scientists On the basis of a questionnaire naar, Delft, The Netherlands; Jerry under 40 years of age in recognition of answered by 94 US biotechnology comPalmer, Seattle, USA; Terry Wilkin, panies, the NSF estimates that R&D ex- recently completed scientific work on Southampton, UK. penditure increased by more than 20% blood transfusion and related subjects.
(~ 1987,
Elsevier Publications,
Cambridge
0167
- 4919/87/$02.00
I
!
i
m,i
. . . . . .
~,~.
~
no¢es-7
,
New PublicationAvailablefor Researchers The fourth edition of Sequences of Proteins of Immunological Interest by Elvin A. Kabat, Tai Te Wu, Margaret ReidMiller, Harold M. Perry and Kay S. Gottesman is now available free of charge to persons working actively in this area. This 1987 revision of the earlier works Variable Regions of Immunoglobulin Chains and Sequences of Proteins of Immunological Interest has been further expanded to include amino acid and nucleotide sequences of precursors, variable regions, constant regions, J-chain, beta-2-microglobulins, antigens of the mouse and human major histocompatibility complex as well as of Thy 1, complement proteins, T-lymphocyte receptors for antigens, other T-cell antigens of the immunoglobulir~ superfamily, interleukins and various other proteins related to immune functions. The publication includes only those sequences which have been published or accepted for publication. As in the earlier editions, the authors used the PROPHETComputer System of the Division of Research Resources, National Institutes of Health to tabulate the data. The collection and maintenance of this database is sponsored by the following components of the National Institutes of Health: Division of Research Resources, National Cancer Institute, National Institute of Allergy and Infectious Diseases, National Institute of A,-t,htitis, Diabetes, Digestive and Kidney Diseases and National Institute of General ivledical Sciences. ~;equences of Proteins of Immunological Interest (fourth edition) is published by the Public Health Service, National Institutes of Health, U.S. Department of Health and Human Services, U.S. Government Printing Office: 1987 165-462. Copies can be obtained free of charge from Harold Perry, BBN Laboratories, Life Sciences Department, 10 Moulton Street, Cambridge, MA 02238, USA.
from $0.9 billion to $1.1 billion in 1985. Because of increased emphasis on health care products, hybridoma development showed the highest growth rates; within the sample companies performance and unemployment levels increased by 36 and 18% respectively. The report also shows that the number of people in the immunology field employed on biotechnology R&D programmes jumped by nearly 25% in the year to January 1986. According to the NSF,two thirds of this increase come from the expansion of a small number of larger companies in immunological markets. As of January 1986, immunologists now account for more than 10% of all scientists and engineers employed in biotechnology research.
In order to qualify, candidates must forward six copies of an unpublished manuscript or of recently published papers, including a curriculum vitae, to the Secretary General* before 10 December 1987. The 3000 SwissFrancs prize will be awarded during the congress.
* InternationalSocietyoi BloodTransfu~on,do CNIS-BP 100-91,943LesUlisCede.x,France.
Pew Schobrsnamed
The Pew Charitable Trusts of Philadelphia have announced the names of the 20 The NKH1/Leu19 antigenon NK cells Pew Scholars in the biomedical sciences for 1987. Recipients of the $200,000 In the paper by C.W. Reynolds and J.R. 4-year research grants are junior faculty Ortaldo (Immunol. Today 1987, 8, 172- members nominated by institutions soli174) the major population of human NK cited by the Pew Trusts. Among the 1987 cells was described as CD3, CD16+, recipients are Nilabh Shastri (UCLA BerLeu19 +. Th. Hercend of the Institut Gus- keley), Michael Snyder (Yale), Adrienne tare Roussy, ViUejuif, France, has pointed Rogalski (Univ. of Illinois), Tucker Collins out that anti-Leu19 antibodies identify (Brigham and Women's Hospital, Bosan antigen not yet included in the CD ton), Alexander Whitehead (Children's classification which he and colleagues Hospital, Boston), Alison Weiss (Virginia identified 1 and characterized2 as an NK Commonwealth Univ.) and Shing Chiu (Univ. Wisconsin, Madison). cell marker and named NKH1. 1 Griffin, J.D., Hercend, T., Beveridge, T.P. and Schlossman, S.F. (1983)J. Immunol. 130, 2947-2951 2 Hercend, T., Griffin, J.D., Bensussan, A. et al. (1985)J. C/in. Invest. 75, 932943
Erratum
We apologise to Helga Gleichmann and G.F. Bottazzo for an error in the caption to the cover photograph in our June ImmunologyCongressReport issue. The caption should have read: Islet-cell antibodies revealed by indirect immunofluorescence on blood The Medical Liaison Service of Sandoz group O human pancreas - a marker Canada Inc., Dorval, Quebec, has pubfor insulin-dependent diabetes and lished a 64-page booklet Congress Repre-diabetes. Lipofuscin granules port which contains abstracts and sumnaturally deposited in the islet stain maries of papers presented at the 1st orange. IUIS Conference on Clinical Immunology and the 6th International Congress of The authors wish to point out that their Immunology held in Toronto in July article was written on behalf of the International Diabetes Workshops Com1986. mittee which is represented by the following members: IndustrialbiotechnologyR&D Gian Franco Bottazzo, Chairman, London, UK; Helga Gleichmann, CoJeanJuillardPrize A recent report from the National Scichairman ar,d Secretary, Dusseldorf, ence Foundation (NSF) reveals that US FRG; Ake Lernmark, Chairman-Elect, The 11th Jean Juillard Prize which was industrial biotechnology research and Gentofte, Denmark; George S. Eisenestablished by the International Society development (R&D) performance topped barth, Treasurer, Boston, USA; Christthe $1 billion mark in 1985. According to of Blood Transfusion in memory of its ian Boitard, Paris, France; Roger L. the report (Science Resources Studies first Secretary General will be awarded Dawkins, Perth, Australia; Hiroo Imduring the XXth International Congress Highlights, NSF 87-304) industrial R&D ura, Kyoto, Japan; Noel K. MacLaren, in the immunological sector is of Blood Tran;fusion to b~ held in LonGainesville, USA; Aaro Miettinen, don, UK from 10 to 15 July 1988. flourishing. Helsinki, Finland; Jacques L. MoleThe prize is reserved for scientists On the basis of a questionnaire naar, Delft, The Netherlands; Jerry under 40 years of age in recognition of answered by 94 US biotechnology comPalmer, Seattle, USA; Terry Wilkin, panies, the NSF estimates that R&D ex- recently completed scientific work on Southampton, UK. penditure increased by more than 20% blood transfusion and related subjects.
(~ 1987,
Elsevier Publications,
Cambridge
0167
- 4919/87/$02.00
I
!